Amy E. Krambeck, MD, on what’s needed to improve safety, efficacy of HoLEP

In this video, Amy E. Krambeck, MD, shares her thoughts on areas for ongoing research and development in the area of holmium laser enucleation of the prostate (HoLEP) for the treatment of benign prostatic hyperplasia. Krambeck is a professor of urology at the Northwestern University Feinberg School of Medicine in Chicago, Illinois.

Transcription:

Based on your experience, what are the key areas for ongoing research and development to further improve the safety and efficacy of HoLEP?

I think the big questions in the field of HoLEP is, how can we make it even more hemostatic and faster? I think the morcellator has improved a lot from when I started. I think it can improve even further. I would also like us to be able to reliably use even smaller scopes, but keep them efficient. I think that's where we're lacking right now. We can use a smaller scope, but not as efficiently as a larger scope. So I think by miniaturizing the equipment, we're going to see huge advancements in the field of HoLEP. And then finally, in training. Training is still our biggest hurdle, and we've seen huge improvements with Ahmed Ghazi and his models that really give you a true replication of what it's like to do a HoLEP, but we need those models to be widely available for people, so that they can learn on a model before trying it on a human. That's where we need to go with this technology.

This transcription was AI generated and edited by human editors for clarity.